Regulation of transferrin receptor 2 in human cancer cell lines

Blood Cells, Molecules, and Diseases

Volumn 42, Issue 1, 2009, Pages 5-13

  Calzolari, Alessia ^a   Finisguerra, Veronica ^a   Oliviero, Isabella ^a   Deaglio, Silvia ^b   Mariani, Gualtiero ^a   Malavasi, Fabio ^b   Testa, Ugo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

c myc; Cancer; Gene expression; Transferrin; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; DEFEROXAMINE; FERRITIN; IMATINIB; IRON REGULATORY PROTEIN 2; MYC PROTEIN; N ACETYL S NITROSOPENICILLAMINE; NITROPRUSSIDE SODIUM; PHOSGENE; TRANSFERRIN RECEPTOR 2;

ARTICLE; CANCER CELL CULTURE; CELL HYPOXIA; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; MELANOMA; OVARY CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIMUTAGENIC AGENTS; APOFERRITINS; CELL HYPOXIA; CELL LINE, TUMOR; COBALT; DEFEROXAMINE; HUMANS; IRON; IRON REGULATORY PROTEIN 2; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PENICILLAMINE; PROTO-ONCOGENE PROTEINS C-MYC; PYRIMIDINES; RECEPTORS, TRANSFERRIN; SIDEROPHORES;

EID: 57949091766     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.10.001     Document Type: Article

References (40)

1. Daniels T.R., Delgado T., Rodriguez J.A., Helguera G., and Penichet M.L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121 (2006) 3915-3921
2. Roualt T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nature Chem. Biol. 2 (2006) 406-414
3. Kawabata H., Yang R., Hirama T., Vuong P.T., Kawano S., Gombart A.F., and Koeffler H.P. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J. Biol. Chem. 275 (1999) 20826-20832
4. Kawabata H., Nakamaki T., Ikonomi P., Smith R.D., Germain R.S., and Koeffler H.P. Expression of transferrin receptor 2 in normal and neoplastic hematopoietic cells. Blood 98 (2001) 2714-2719
5. Fleming R.S., Migas M.C., Holden C.C., Waheed A., Britton R.S., Tomatsu S., Bacon B.R., and Sly W.S. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 2214-2219
6. Calzolari A., Deaglio S., Sposi N.M., Petrucci E., Morsilli O., Gabbianelli M., Malavasi F., Peschle C., and Testa U. Transferrin receptor 2 is not expressed in normal erythroid cells. Biochem. J. 381 (2004) 629-634
7. Kawabata H., Germani R.S., Vuong P.T., Nakamaki T., Said J.W., and Koeffler H.P. Transferrin receptor 2-α supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275 (2000) 16618-16625
8. Levy J.E., Jin O., Fujiwara Y., Kuo F., and Andrews N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21 (1999) 396-399
9. Camaschella C., Roetto A., Cali A., Camaschella C., Roetto A., Calì A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., and Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25 (2000) 14-15
10. Roetto A., Totano A., Piperno A., Roetto A., Totaro A., Piperno A., Piga A., Longo F., Garozzo G., Calì A., De Gobbi M., Gasparini P., and Camaschella C. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood 97 (2001) 2555-2560
11. Calzolari A., Raggi C., Deaglio S., Sposi N.M., Stafnes M., Fecchi K., Malavasi F., Peschle C., Sargiacomo M., and Testa U. TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell. Sci. 119 (2006) 4486-4498
12. Richardson D.R., Neummannova V., Nagy E., and Ponka P. The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells. Blood 86 (1995) 3211-3219
13. Kim S., and Ponka P. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein-2. J. Biol. Chem. 274 (1999) 33035-33042
14. Toth I., Yuan L., Rogers J.T., Boyce H., and Bridges K.R. Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J. Biol. Chem. 274 (1999) 4467-4473
15. Tacchini L., Bianchi L., Bernelli-Zazzera A., and Cairo G. Transferrin receptor induction by hypoxia. J. Biol. Chem. 274 (1999) 24142-24146
16. Wu K.J., Polack A., and Dalla Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-Myc. Science 283 (1999) 676-679
17. Bowen H., Biggs T.E., Baker S.T., Phillips E., Perry V.H., Mann D.A., and Barton C.H. C-Myc represses the murine Nramp1 promoter. Biochem. Soc. Trans. 30 (2002) 774-777
18. Bayele H.K., McArdle H., and Srai S. Cis and trans regulation of hepcidin expression by upstream stimulatory factors. Blood 108 (2006) 4237-4245
19. O'Donnell K.A., Yu D., Zeller K.I., Kim J.W., Racke F., Thomas-Tikhonenko A., and Dang C.V. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell Biol. 26 (2006) 2373-2386
20. Gatter K.C., Brown G., Trowbridge I.S., Woolston R.E., and Mason D.Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol. 36 (1983) 539-545
21. Ellwood-Yen K., Graeber T.G., Wongvipat J., Iruela-Arispe M.L., Zhang J., Matusik R., Thomas G.V., and Sawyers C.L. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell. 4 (2003) 223-238
22. Habel M.E., Lemieux R., and Jung D. Iron specific growth inhibition of Burkitt's lymphoma cells in vitro, associated with a decrease in translocated c-myc expression. J. Cell Physiol. 203 (2005) 277-285
23. Habel M.E., and Jung D. C-Myc overexpression in Ramos Burkitt's lymphoma cell line predisposes to iron homeostasis disruption in vitro. Biochem. Biophys. Res. Commun. 341 (2006) 1309-1316
24. Calzolari A., Oliviero I., Deaglio S., Mariani G., Biffoni M., Sposi N.M., Malavasi F., Peschle C., and Testa U. Transferrin receptor 2 is frequently expressed in cancer cell lines. Blood Cells Mol. Dis. 39 (2007) 82-91
25. Deaglio S., Capobianco A., Calì A., Bellora F., Alberti F., Righi L., Sapino A., Camaschella C., and Malavasi F. Structural, functional, and tissue distribution analysis of human trasferrin receptor-2 by murine monoclonal antibodies and a polyclonal serum. Blood 100 (2002) 3782-3789
26. Kyriakon D., Eliopoulos A.G., Popadakis A., Lexandris M., and Eliopoulos G.D. Decreased expression of c-myc oncoprotein by peripheral blood mononuclear cells in thalassemia patients receiving desferoxamine. Eur. J. Haematol. 60 (1998) 21-27
27. Huang M., Dorsey J.F., Epling-Burnette P.K., Nimmanapalli R., Landowski T.H., Mora L.B., Niu G., Sinibaldi D., Bai F., Kraker A., Yu H., Moscinski L., Wei S., Djeu J., Dalton W.S., Bhalla K., Loughran T.P., Wu J., and Jove R. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells. Oncogene 21 (2002) 8804-8816
28. Gomez-Casares M.T., Vaqué J.P., Lennes A., Molero T., Delgado M.D., and Leon J. c-myc expression in cell lines derived from chronic myeloid leukaemia. Haematologica 89 (2004) 241-243
29. Wallander M.L., Leibold E.A., and Eisenstein R.S. Molecular control of vertebrate iron homeostasis by iron regulatory proteins. Biochim. Biophys. Acta. 1763 (2006) 668-689
30. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
31. Xie S., Lin H., Sun T., and Arlinghaus R.B. JAK2 is involved in c-Myc induction by Bcr-Abl. Oncogene 21 (2002) 7137-7146
32. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vaulont S., Haase V.H., Nizet V., and Johnson R.S. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 117 (2007) 1926-1932
33. Graham R.M., Chua A.C., Herbison C.E., Olynyk J.K., and Trinder D. World J. Iron transport Gastroenter. 13 (2007) 4725-4736
34. Calzolari A., Oliviero I., and Testa U. Transferrin receptor 2 is emerging as a major player in the control of iron metabolism. Central J. Biol. 2 (2007) 34-55
35. Pietrangelo A. Hemochromatosis-an endocrine liver disease. Hepatology 46 (2007) 1291-1301
36. Darsham D., and Anderson D.J. Liver-gut axis in the regulation of iron homeostasis. World J. Gastroenter. 13 (2007) 4737-4745
37. Oates P.S., and Ahmed U. Molecular regulation of hepatic expression of iron regulatory hormone hepcidin. J. Gastr. Hepatol. 22 (2007) 1378-1387
38. Yu P.B., Hong C.C., Sachidanandan C., Babbit J.L., Deng D.Y., Hoyng S.A., Lin H.Y., Bloch K.D., and Peterson R.T. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nature Chem. Biol. 4 (2008) 33-41
39. Yoon D., Pastore Y.D., Divoky V., Liu E., Mlodnicka A.E., Rainey K., Ponka P., Semenza G.L., and Prchal J.T. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J. Biol. Chem. 281 (2006) 25703-25711
40. Choi S.O., Cho Y.S., Kim H.L., and Park J.W. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting c/EBP alpha and STAT-3. Biochem. Biophys. Res. Commun. 356 (2007) 312-317